Study Takes Fine-Grained Look at MACE Risk With GCs in RA : vimarsana.com

'Up to half of RA patients in the United States use long-term glucocorticoids despite previous work suggesting they increase MACE in a dose-dependent way.'

Related Keywords

Ann Arbor , Michigan , United States , Philadelphia , Pennsylvania , University Of Pennsylvania , Beth Wallace , Michael George , European Alliance Of Associations , Va Ann Arbor Healthcare Center , Glaxosmithkline , American College Of Rheumatology , Veterans Affairs , University Of Michigan , American College , Arbor Healthcare , European Alliance , Cv , Ardiovascular , Glucocorticosteroids , Biologic Therapy , Rheumatoid Arthritis , A , Heart Failure , Lipids , Ipid Management , Opioids , Arthritis , Oint Inflammation , Body Mass Index Bmi , Cancer , Alignant Neoplasia , Arcinoma , Cardiac Arrest , Cardiovascular Disease , Vd Cardiovascular Disease , Disease Modifying Antirheumatic Drugs Dmards , Mard Disease Modifying Antirheumatic Dr ,